Clinical Trials
7 trialsNCT05812807 2026-06-05
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT05333874 2026-02-09
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Active not recruiting
NCT07262138 2025-12-03
ACTIVE
University of Pittsburgh
Recruiting
NCT04625023 2025-05-01
METAMECH
IFOM ETS - The AIRC Institute of Molecular Oncology
Recruiting
NCT00080756 2024-08-28
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
City of Hope Medical Center
Phase 2 Active not recruiting
NCT03161834 2021-05-21
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Withdrawn
NCT01867229 2019-04-10
chemo-ameno
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Completed